These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16195840)

  • 1. The road to bioabsorbable stents: reaching clinical reality?
    Erne P; Schier M; Resink TJ
    Cardiovasc Intervent Radiol; 2006; 29(1):11-6. PubMed ID: 16195840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promise and challenges of bioabsorbable stents.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
    Pendyala L; Jabara R; Robinson K; Chronos N
    J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting bioabsorbable magnesium stent.
    Di Mario C; Griffiths H; Goktekin O; Peeters N; Verbist J; Bosiers M; Deloose K; Heublein B; Rohde R; Kasese V; Ilsley C; Erbel R
    J Interv Cardiol; 2004 Dec; 17(6):391-5. PubMed ID: 15546291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable stents.
    Ramcharitar S; Serruys PW
    Minerva Cardioangiol; 2008 Apr; 56(2):205-13. PubMed ID: 18319699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on bioabsorbable stents: from bench to clinical.
    Waksman R
    J Interv Cardiol; 2006 Oct; 19(5):414-21. PubMed ID: 17020566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
    Bangalore S; Mauri L
    EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymers, drug release, and drug-eluting stents.
    Commandeur S; van Beusekom HM; van der Giessen WJ
    J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local vascular toxicokinetics of stent-based drug delivery.
    Tesfamariam B
    Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?
    Brodie BR
    J Interv Cardiol; 2006 Feb; 19(1):43-50. PubMed ID: 16483339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.